Sensura provides a non‑invasive continuous glucose monitoring device that uses optical sensors to measure blood sugar through the skin without finger pricks. The system streams real‑time readings to a mobile app with trend analytics, alerts and cloud‑based storage for long‑term tracking and clinician sharing, offering painless, continuous monitoring for people with diabetes.
Funding
Funding not disclosed
Founders
Product
Problem
People with diabetes must perform frequent finger‑stick tests to monitor blood glucose, which are painful, inconvenient, and provide only intermittent data, limiting effective disease management.
Solution
Sensura offers a non‑invasive continuous glucose monitoring (CGM) device that uses advanced optical sensors to measure blood sugar levels through the skin without puncture. The sensor continuously captures glucose data and transmits it to a companion app where real‑time analytics display current readings and trend information. By eliminating the need for disposable test strips and finger pricks, the system simplifies daily monitoring and helps users make timely lifestyle or medication adjustments. The platform integrates secure cloud storage for historical data, enabling long‑term pattern analysis and sharing of results with healthcare providers.
Target Audience
Primary customers are individuals with type 1 or type 2 diabetes seeking painless, continuous glucose monitoring, as well as endocrinologists and diabetes care clinics that monitor patient data remotely.
Features
- Optical sensing technology that detects glucose concentrations through the skin without blood draws
- Continuous real‑time glucose readings updated at frequent intervals
- Mobile app dashboard with trend graphs, alerts for hypo‑ and hyper‑glycemia, and customizable notifications
- Cloud‑based data storage for longitudinal tracking and easy export to clinicians
- Battery‑efficient design supporting multi‑day wear and wireless charging
- Compatibility with major smartphone operating systems (iOS and Android)